Clinical efficacy and safety of transarterial chemoembolization combined with targeted therapy and PD1 inhibitors in patients with advanced liver cancer
TACE combined with targeted therapy and PD1 inhibitors is significantly effective to improve the cellular immune function with no significant increase in the incidence of adverse reactions, making it an effective and safe treatment option for patients with liver cancer.
Authors
- Yuanlong Zhou (ORCID: https://orcid.org/0000-0001-9091-0021)
- Zan Li (ORCID: https://orcid.org/0009-0007-3793-4236)
- Yuan Wang (ORCID: https://orcid.org/0000-0003-0424-8583)
- Linwei Kang
- Jisen Zhao
Institutions
- Affiliated Hospital of Hebei University (CN)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2025-02-21
- DOI
- https://doi.org/10.12669/pjms.41.3.9799
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00